Artigos relacionados
Imunoterapia
Therapeutic approach reinforced by tarlatamab plus durvalumab and other agents in aggressive cancers.
Artigos relacionados
Therapeutic approach reinforced by tarlatamab plus durvalumab and other agents in aggressive cancers.